---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-077304"
form_type: "8-K"
ticker: "CPHI"
cik: "0001106644"
company_name: "CHINA PHARMA HOLDINGS, INC."
filed_at: "2022-12-02T23:59:59+00:00"
generated_at: "2026-06-21T10:04:43.512222+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# China Pharma receives NYSE American deficiency notice for equity shortfall

## Summary
- Stockholders' equity of $2.8M as of Sept 30, 2022 below the $4.0M minimum required by Section 1003(a)(ii).
- Company has reported net losses in four most recent fiscal years ended Dec 31, 2021.
- Must regain compliance with equity standard by Dec 15, 2023, and price noncompliance by March 26, 2023.
- NYSE American accepted a plan on Aug 29, 2022 to cure equity noncompliance; failure to progress may trigger delisting.
- Common stock (CPHI) continues trading with .BC indicator while company attempts to cure deficiencies.

## SEC filing metadata
- accession: 0001213900-22-077304
- form_type: 8-K
- ticker: CPHI
- cik: 0001106644
- company_name: CHINA PHARMA HOLDINGS, INC.
- filed_at: 2022-12-02T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1106644/000121390022077304/0001213900-22-077304-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1106644/000121390022077304/ea169585-8k_chinapharma.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-077304
- JSON: https://secwatch.observer/filing/0001213900-22-077304.json
- Plain text: https://secwatch.observer/filing/0001213900-22-077304.txt

## Key facts
- Listing & Compliance Notices
  CHINA PHARMA HOLDINGS, INC. received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)(ii)).
  - Exchange: nyse american
  - Notice: deficiency notice
  - Deficiency: stockholders equity
  - Rules: 1003(a)(ii)
  source text: if it has reported losses from continuing operations and/or net losses in its four most recent fiscal years. The Deficiency Letter noted that Company had stockholders’ equity of $2.8 million as of September 30, 2022, and has reported losses from continuing operations and/or net losses in its four most recent fiscal years ended December 31, 2021. The Company remains
  evidence_url: https://www.sec.gov/Archives/edgar/data/1106644/000121390022077304/0001213900-22-077304-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.